Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.
| Manufacturer ▼ | Drug Name | Indication | Stage | Status | Route of Administration | Drug Class |
|---|---|---|---|---|---|---|
| NovoCure Limited | Tumor Treating Fields (TTFields) with pembrolizumab and temozolomide - (TIGER) | Glioblastoma (GBM) | Phase 2 | Ongoing | TTFields are administered via transducer arrays on the scalp pembrolizumab is administered intravenously temozolomide is administered orally | Oncology |
| NovoCure Limited | EF-33 | Recurrent glioblastoma | Phase 2 | Trial Completed | Intravenous | Oncology |
| NovoCure Limited | TTFields (EF-31) | Gastric cancer | Phase 2 | Trial Planned | Transdermal | Oncology |
| NovoCure Limited | Tumor Treating Fields (TTFields) - (HEPANOVA) | Liver cancer | Phase 2 | Trial Completed | Transdermal | Oncology |
| NRX Pharmaceuticals Inc. | KETAFREE | Preservative-free intravenous ketamine formulation | PDUFA | Ongoing | Intranasal | Anesthetic |
| NRX Pharmaceuticals Inc. | NRX-101 | Bipolar Depression and Suicidal Ideation | NDA Filing | Ongoing | Oral | Psychiatric |
| NRX Pharmaceuticals Inc. | NRX-101 | Bipolar Depression and Suicidal Ideation | NDA Filing | Ongoing | Oral | Psychiatric |
| NRX Pharmaceuticals Inc. | HTX-100 (NRX-100) (Ketamine Hydrochloride) | Acute Suicidal Ideation and Behavior in Bipolar Depression | Phase 3 | Data Released | Intravenous | Psychiatric |
